Using Procalcitonin For Assessing Risk Over Time
In the ICU, in the Emergency Department, in patient wards — VIDAS® B•R•A•H•M•S PCT™ (Procalcitonin) can aid in sepsis risk assessment and deliver key data related to bacterial infection severity, at initial presentation and over the course of treatment.
In treating sepsis, The first hour can be critical and the First 24 can be decisive.
Sepsis can be extremely difficult to diagnose because its primary symptoms mimic the symptoms of several other critical care conditions, including myocardial infarction, pneumonia, pulmonary embolism and other high-morbidity conditions. And because of the aggressive nature of sepsis, diagnosing and initiating treatment of this infection needs to happen as soon as possible. Access to specific information may increase the accuracy of sepsis diagnostics during the critical early stages.
PCT Kinetics Over Time Provide Valuable Information
In managing critically ill patients, serial measurements over multiple days can support assessment of that patient's response to therapy. As the infection is controlled, PCT will decline daily.
The need for more effective strategies to help manage sepsis is urgent
This site was developed to increase awareness and share knowledge related to the use of Procalcitonin and other testing techniques and systems that can be used in diagnosing, treating and managing sepsis.